Home - Products - Others - Other Targets - TFLLR-NH2 2TFA(197794-83-5(free base))

TFLLR-NH2 2TFA(197794-83-5(free base))

CAS No.

TFLLR-NH2 2TFA(197794-83-5(free base)) ( —— )

Catalog No. M22777 CAS No.

TFLLR-NH2(2TFA) is an agonist of PAR1 (EC50 :1.9 μM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 609 In Stock
10MG 1017 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TFLLR-NH2 2TFA(197794-83-5(free base))
  • Note
    Research use only, not for human use.
  • Brief Description
    TFLLR-NH2(2TFA) is an agonist of PAR1 (EC50 :1.9 μM).
  • Description
    TFLLR-NH2(2TFA) is an agonist of PAR1 (EC50 :1.9 μM).
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    PAR1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    --
  • Formula Weight
    647.81
  • Molecular Formula
    C31H53N9O6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC(=O)C(F)(F)F.CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kawabata A , Kuroda R , Kuroki N , et al. Characterization of the protease-activated receptor-1-mediated contraction and relaxation in the rat duodenal smooth muscle[J]. Life Sciences, 2000, 67(20):0-2530.
molnova catalog
related products
  • 4-O-Caffeoyl-3-O-syr...

    4-O-Caffeoyl-3-O-syringoylquinic acid

  • Methyl pentadecanoat...

    Methyl pentadecanoate is a natural product.Methyl pentadecanoate is a saturated fatty acid methyl ester obtained from the esterification of myristic acid. Methyl myristate shows a high melanin induction in B16F10 melanoma.

  • (S/R)-Orteronel

    TAK-700 (Orteronel) is a potent and highly selective human 17, 20-lyase inhibitor with IC50 of 38 nM, exhibits >1000-fold selectivity over other CYPs (e.g. 11-hydroxylase and CYP3A4). Phase 3.